Inspire vs Genio Sleep Apnea Implants 2026: Which Hypoglossal Stimulator Wins?
By Dr. Sarah Mitchell, Respiratory Equipment Specialist · Published 2026-06-03 · 9 min read
For CPAP-intolerant patients, hypoglossal nerve stimulators now eliminate OSA in 78% of users. Inspire IV vs Nyxoah Genio compared.
CPAP-Free Sleep Apnea Treatment
Hypoglossal nerve stimulators activate the tongue muscle during sleep to keep the airway open — no mask, no hose.
Inspire IV (2026 update)
- Single implanted pulse generator + sensor + lead
- 11-year battery, MRI conditional (1.5T full body, 3T head)
- BMI cutoff raised to 40
- New "smart sensing" algorithm reduces false stimulation by 38%
Genio (Nyxoah)
- Battery-free implant — external rechargeable patch worn nightly
- Bilateral stimulation (Inspire is unilateral)
- Fully MRI compatible
- DREAM trial: AHI reduction 60%
Head-to-Head
| Feature | Inspire IV | Genio |
|---|---|---|
| Battery | Internal (11 yr) | External patch |
| MRI | Conditional | Full |
| Stimulation | Unilateral | Bilateral |
| BMI limit | 40 | 35 |
Who Still Needs CPAP First
Hypoglossal stimulators are not first-line. Try CPAP for 3-6 months with a comfortable CPAP mask. If you cannot tolerate it, ask about implant eligibility.